These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 17392720

  • 1. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
    Ryu JY, Song IS, Sunwoo YE, Shon JH, Liu KH, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2007 Nov; 82(5):531-40. PubMed ID: 17392720
    [Abstract] [Full Text] [Related]

  • 2. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS, Bleakley JF, Kim JS, Nafziger AN, Leeder JS, Gaedigk A, Gotschall R, Kearns GL, Bertino JS.
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [Abstract] [Full Text] [Related]

  • 3. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S, Nafziger AN, Leeder JS, Gaedigk A, Kearns GL, Sellers E, Zhang Y, Kashuba AD, Rowland E, Bertino JS.
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M, Samer C, Déglon J, Thomas A, Walder B, Desmeules J, Daali Y.
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [Abstract] [Full Text] [Related]

  • 5. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
    Yeh RF, Gaver VE, Patterson KB, Rezk NL, Baxter-Meheux F, Blake MJ, Eron JJ, Klein CE, Rublein JC, Kashuba AD.
    J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
    [Abstract] [Full Text] [Related]

  • 6. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.
    de Andrés F, Terán S, Bovera M, Fariñas H, Terán E, LLerena A.
    OMICS; 2016 Feb; 20(2):88-96. PubMed ID: 26600202
    [Abstract] [Full Text] [Related]

  • 7. Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?
    Magalhães P, De Andrés F, Falcão A, LLerena A, Alves G.
    J Pharm Pharm Sci; 2016 Feb; 19(4):520-529. PubMed ID: 28057170
    [Abstract] [Full Text] [Related]

  • 8. Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis.
    Jenkins J, Williams D, Deng Y, Collins DA, Kitchen VS.
    Eur J Clin Pharmacol; 2010 Jan; 66(1):67-76. PubMed ID: 19756558
    [Abstract] [Full Text] [Related]

  • 9. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
    Tennezé L, Verstuyft C, Becquemont L, Poirier JM, Wilkinson GR, Funck-Brentano C.
    Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
    [Abstract] [Full Text] [Related]

  • 10. Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5+1 Cocktail.
    Mohamed MF, Feng T, Enejosa JV, Fisniku O, Othman AA.
    J Clin Pharmacol; 2020 Jan; 60(1):86-95. PubMed ID: 31378969
    [Abstract] [Full Text] [Related]

  • 11. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
    Derungs A, Donzelli M, Berger B, Noppen C, Krähenbühl S, Haschke M.
    Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
    [Abstract] [Full Text] [Related]

  • 12. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.
    Kim MG, Kim Y, Jeon JY, Kim DS.
    Br J Clin Pharmacol; 2016 Dec; 82(6):1580-1590. PubMed ID: 27495955
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail.
    Johnson BM, Song IH, Adkison KK, Borland J, Fang L, Lou Y, Berrey MM, Nafziger AN, Piscitelli SC, Bertino JS.
    J Clin Pharmacol; 2006 May; 46(5):577-87. PubMed ID: 16638741
    [Abstract] [Full Text] [Related]

  • 14. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans.
    Lammers LA, Achterbergh R, de Vries EM, van Nierop FS, Klümpen HJ, Soeters MR, Boelen A, Romijn JA, Mathôt RA.
    Drug Metab Dispos; 2015 Jun; 43(6):819-28. PubMed ID: 25795462
    [Abstract] [Full Text] [Related]

  • 15. Assessment of cytochrome P450 activity by a five-drug cocktail approach.
    Zhu B, Ou-Yang DS, Chen XP, Huang SL, Tan ZR, He N, Zhou HH.
    Clin Pharmacol Ther; 2001 Nov; 70(5):455-61. PubMed ID: 11719732
    [Abstract] [Full Text] [Related]

  • 16. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S, Song N, Li Q, Fan H, Liu C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug 01; 871(1):78-89. PubMed ID: 18614408
    [Abstract] [Full Text] [Related]

  • 17. Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.
    Wennerholm A, Nordmark A, Pihlsgård M, Mahindi M, Bertilsson L, Gustafsson LL.
    Eur J Clin Pharmacol; 2006 Jul 01; 62(7):539-46. PubMed ID: 16783563
    [Abstract] [Full Text] [Related]

  • 18. A Cocktail Interaction Study Evaluating the Drug-Drug Interaction Potential of the Perpetrator Drug ASP8477 at Multiple Ascending Dose Levels.
    Treijtel N, Collins C, van Bruijnsvoort M, Fuhr R, Ernault E, Gangaram-Panday S, Passier P.
    Clin Pharmacol Drug Dev; 2019 May 01; 8(4):529-540. PubMed ID: 30730615
    [Abstract] [Full Text] [Related]

  • 19. Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
    Chen XP, Tan ZR, Huang SL, Huang Z, Ou-Yang DS, Zhou HH.
    Clin Pharmacol Ther; 2003 Mar 01; 73(3):264-71. PubMed ID: 12621391
    [Abstract] [Full Text] [Related]

  • 20. An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.
    Tamminga WJ, Wemer J, Oosterhuis B, Brakenhoff JP, Gerrits MG, de Zeeuw RA, de Leij LF, Jonkman JH.
    Eur J Clin Pharmacol; 2001 May 01; 57(2):143-6. PubMed ID: 11417446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.